% | $
Quotes you view appear here for quick access.

OncoGenex Pharmaceuticals, Inc. Message Board

  • mattgrable268 Jul 3, 2013 2:53 PM Flag

    Old phase II OGX-011 trial question

    Im new to the stock and doing my research on custirsen, I'm looking at the phase 2 trial in Journal of Clinical Oncology from 2010, looking at the baseline predicted 24-month survival rate they list a median 25.6%, with 95% confidence interval 20.4 to 31.0% for treatment arm baseline, compared to 19.6% median with 95% CI of 19.0 to 29.4% for placebo.

    My question is whether the median for the placebo group is correct? I haven't seen a case where the median could be so far towards one end of the 95% confidence interval, typically it would be pretty near the middle as it was in the treatment arm. Anyone better at stats than me that can provide some insight?

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.5079+0.0179(+3.65%)Sep 27 4:00 PMEDT